Pharmaceutical Innovation and Access to Medicines
This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the increas...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Paris
OECD Publishing
2018
|
| Schriftenreihe: | OECD Health Policy Studies
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046961690 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201027s2018 xx o|||| 00||| eng d | ||
| 020 | |a 9789264307391 |9 978-92-64-30739-1 | ||
| 020 | |a 9789264311145 |9 978-92-64-31114-5 | ||
| 020 | |a 9789264311329 |9 978-92-64-31132-9 | ||
| 024 | 7 | |a 10.1787/9789264307391-en |2 doi | |
| 035 | |a (ZDB-13-SOC)052068552 | ||
| 035 | |a (OCoLC)1220916757 | ||
| 035 | |a (DE-599)BVBBV046961690 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-384 |a DE-473 |a DE-824 |a DE-29 |a DE-739 |a DE-355 |a DE-20 |a DE-1028 |a DE-1049 |a DE-521 |a DE-861 |a DE-898 |a DE-92 |a DE-188 |a DE-91 |a DE-573 |a DE-19 | ||
| 245 | 1 | 0 | |a Pharmaceutical Innovation and Access to Medicines |c Organisation for Economic Co-operation and Development |
| 264 | 1 | |a Paris |b OECD Publishing |c 2018 | |
| 300 | |a 1 Online-Ressource (192 Seiten) |c 21 x 28cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a OECD Health Policy Studies | |
| 520 | |a This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the increasing prices of new medicines; concerns about the value of spending in some therapeutic areas; challenges in anticipating the arrival of very effective medicines for highly prevalent diseases; sharp price increases in off-patent products; and the apparent misalignment of current incentives for the development of treatments for certain conditions. The report also describes the role of the biopharmaceutical industry in OECD economies, examines the process of pharmaceutical R&D and its financing, and looks at the risks, costs and return from R&D investment for the industry. Examining trends in the industry over time, it shows that productivity of R&D expenditure has declined; that the duration of market exclusivity has remained relatively stable; that new medicines are increasingly being developed for small patient populations; and that the industry as a whole has remained highly profitable for investors. Lastly, the report presents a range of policy options for consideration by policy makers, to support the development of effective and co-ordinated responses to the identified challenges | ||
| 650 | 4 | |a Social Issues/Migration/Health | |
| 856 | 4 | 0 | |u https://doi.org/10.1787/9789264307391-en |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ZDB-13-SOC | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-032370014 | |
Datensatz im Suchindex
| DE-BY-TUM_katkey | 2545242 |
|---|---|
| DE-BY-UBM_katkey | 5945889 |
| DE-BY-UBR_katkey | 6339137 |
| _version_ | 1823057157600313344 |
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV046961690 |
| collection | ZDB-13-SOC |
| ctrlnum | (ZDB-13-SOC)052068552 (OCoLC)1220916757 (DE-599)BVBBV046961690 |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1787/9789264307391-en |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV046961690</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201027s2018 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789264307391</subfield><subfield code="9">978-92-64-30739-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789264311145</subfield><subfield code="9">978-92-64-31114-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789264311329</subfield><subfield code="9">978-92-64-31132-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/9789264307391-en</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-13-SOC)052068552</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220916757</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046961690</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-861</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Innovation and Access to Medicines</subfield><subfield code="c">Organisation for Economic Co-operation and Development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (192 Seiten)</subfield><subfield code="c">21 x 28cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Health Policy Studies</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the increasing prices of new medicines; concerns about the value of spending in some therapeutic areas; challenges in anticipating the arrival of very effective medicines for highly prevalent diseases; sharp price increases in off-patent products; and the apparent misalignment of current incentives for the development of treatments for certain conditions. The report also describes the role of the biopharmaceutical industry in OECD economies, examines the process of pharmaceutical R&D and its financing, and looks at the risks, costs and return from R&D investment for the industry. Examining trends in the industry over time, it shows that productivity of R&D expenditure has declined; that the duration of market exclusivity has remained relatively stable; that new medicines are increasingly being developed for small patient populations; and that the industry as a whole has remained highly profitable for investors. Lastly, the report presents a range of policy options for consideration by policy makers, to support the development of effective and co-ordinated responses to the identified challenges</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1787/9789264307391-en</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032370014</subfield></datafield></record></collection> |
| id | DE-604.BV046961690 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-03T17:57:29Z |
| institution | BVB |
| isbn | 9789264307391 9789264311145 9789264311329 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032370014 |
| oclc_num | 1220916757 |
| open_access_boolean | 1 |
| owner | DE-384 DE-473 DE-BY-UBG DE-824 DE-29 DE-739 DE-355 DE-BY-UBR DE-20 DE-1028 DE-1049 DE-521 DE-861 DE-898 DE-BY-UBR DE-92 DE-188 DE-91 DE-BY-TUM DE-573 DE-19 DE-BY-UBM |
| owner_facet | DE-384 DE-473 DE-BY-UBG DE-824 DE-29 DE-739 DE-355 DE-BY-UBR DE-20 DE-1028 DE-1049 DE-521 DE-861 DE-898 DE-BY-UBR DE-92 DE-188 DE-91 DE-BY-TUM DE-573 DE-19 DE-BY-UBM |
| physical | 1 Online-Ressource (192 Seiten) 21 x 28cm |
| psigel | ZDB-13-SOC |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | OECD Publishing |
| record_format | marc |
| series2 | OECD Health Policy Studies |
| spellingShingle | Pharmaceutical Innovation and Access to Medicines Social Issues/Migration/Health |
| title | Pharmaceutical Innovation and Access to Medicines |
| title_auth | Pharmaceutical Innovation and Access to Medicines |
| title_exact_search | Pharmaceutical Innovation and Access to Medicines |
| title_full | Pharmaceutical Innovation and Access to Medicines Organisation for Economic Co-operation and Development |
| title_fullStr | Pharmaceutical Innovation and Access to Medicines Organisation for Economic Co-operation and Development |
| title_full_unstemmed | Pharmaceutical Innovation and Access to Medicines Organisation for Economic Co-operation and Development |
| title_short | Pharmaceutical Innovation and Access to Medicines |
| title_sort | pharmaceutical innovation and access to medicines |
| topic | Social Issues/Migration/Health |
| topic_facet | Social Issues/Migration/Health |
| url | https://doi.org/10.1787/9789264307391-en |